SLC18B1
MFS-type transporter SLC18B1
Also known as: C6orf192, dJ55C23.6, S18B1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6NT16
- Gene
- SLC18B1
- Ensembl
- ENSG00000146409
- Chromosome
- 6
- Canonical length
- 456 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus,Cytosol
OverviewNCBI Gene
This gene encodes a protein, which has high sequence similarity to rat, xenopus and zebrafish proteins. The protein function is unknown. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
456 residues, UniProt reviewed canonical sequence.
>Q6NT16|SLC18B1
1 MEALGDLEGP RAPGGDDPAG SAGETPGWLS REQVFVLISA ASVNLGSMMC YSILGPFFPK
61 EAEKKGASNT IIGMIFGCFA LFELLASLVF GNYLVHIGAK FMFVAGMFVS GGVTILFGVL
121 DRVPDGPVFI AMCFLVRVMD AVSFAAAMTA SSSILAKAFP NNVATVLGSL ETFSGLGLIL
181 GPPVGGFLYQ SFGYEVPFIV LGCVVLLMVP LNMYILPNYE SDPGEHSFWK LIALPKVGLI
241 AFVINSLSSC FGFLDPTLSL FVLEKFNLPA GYVGLVFLGM ALSYAISSPL FGLLSDKRPP
301 LRKWLLVFGN LITAGCYMLL GPVPILHIKS QLWLLVLILV VSGLSAGMSI IPTFPEILSC
361 AHENGFEEGL STLGLVSGLF SAMWSIGAFM GPTLGGFLYE KIGFEWAAAI QGLWALISGL
421 AMGLFYLLEY SRRKRSKSQN ILSTEEERTT LLPNETLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC18B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 28 nTPM
- amygdala: 28 nTPM
- choroid plexus: 24 nTPM
- basal ganglia: 23 nTPM
- midbrain: 21 nTPM
- hippocampal formation: 20 nTPM
Single-cell type
- bergmann glia: 167 nCPM
- hofbauer cells: 158 nCPM
- astrocytes: 143 nCPM
- choroid plexus epithelial cells: 125 nCPM
- ependymal cells: 100 nCPM
- oligodendrocyte progenitor cells: 78 nCPM
Immune cell
- myeloid DC: 20 nTPM
- plasmacytoid DC: 16 nTPM
- classical monocyte: 15 nTPM
- T-reg: 12 nTPM
- naive B-cell: 9.8 nTPM
- naive CD4 T-cell: 9.5 nTPM
Brain region
- thalamus: 28 nTPM
- choroid plexus: 24 nTPM
- spinal cord: 23 nTPM
- white matter: 22 nTPM
- midbrain: 22 nTPM
- cerebellum: 22 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.51
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.38
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- monoamine:proton antiporter activity
- transmembrane transporter activity
- polyamine:proton antiporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC18B1 as an antibody target. Whether an autoantibody or antibody against SLC18B1 could matter depends on whether native SLC18B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC18B1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC18B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...